BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Wang C, Xu P, Li X, Lu Y, Jin D, Yin X, Jiang H, Huang J, Xiong H, Ye F, Jin J, Chen Y, Xie Y, Chen Z, Ding H, Zhang H, Liu R, Jiang H, Chen K, Yao Z, Luo C, Huang Y, Zhang Y, Zhang J. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Theranostics 2021;11:5387-403. [PMID: 33859753 DOI: 10.7150/thno.42345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Karner C, Anders I, Vejzovic D, Szkandera J, Scheipl S, Deutsch AJA, Weiss L, Vierlinger K, Kolb D, Kühberger S, Heitzer E, Habisch H, Zhang F, Madl T, Reininger-gutmann B, Liegl-atzwanger B, Rinner B. Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.. [DOI: 10.21203/rs.3.rs-2190208/v1] [Reference Citation Analysis]
2 Qu L, He X, Tang Q, Fan X, Liu J, Lin A. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns. J Zhejiang Univ Sci B 2022;23:844-62. [PMID: 36226538 DOI: 10.1631/jzus.B2200194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wang C, Dong L, Zhao Z, Zhang Z, Sun Y, Li C, Li G, You X, Yang X, Wang H, Hong W. Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell. Front Chem 2022;10:888727. [PMID: 35755248 DOI: 10.3389/fchem.2022.888727] [Reference Citation Analysis]
4 Wang Z, Xiong L, Xiong Q. Purification and Identification of Natural Inhibitors of Protein Arginine Methyltransferases from Plants. Mol Cell Biol 2022;:e0052321. [PMID: 35311588 DOI: 10.1128/mcb.00523-21] [Reference Citation Analysis]
5 Suresh S, Huard S, Brisson A, Némati F, Dakroub R, Poulard C, Ye M, Martel E, Reyes C, Silvestre DC, Meseure D, Nicolas A, Gentien D, Fayyad-Kazan H, Le Romancer M, Decaudin D, Roman-Roman S, Dubois T. PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer. Cancers (Basel) 2022;14:306. [PMID: 35053470 DOI: 10.3390/cancers14020306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Suresh S, Huard S, Brisson A, Némati F, Poulard C, Ye M, Martel E, Reyes C, Silvestre DC, Meseure D, Nicolas A, Gentien D, Le Romancer M, Decaudin D, Roman-roman S, Dubois T. PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer.. [DOI: 10.1101/2021.10.22.465320] [Reference Citation Analysis]
7 Lu X, Meng J, Zhou Y, Wang H, Ruan X, Chen Y, Ye Y, Su L, Fan X, Yan H, Jiang L, Yan F. DNA replication stress stratifies prognosis and enables exploitable therapeutic vulnerabilities of HBV-associated hepatocellular carcinoma: an in silico strategy towards precision oncology.. [DOI: 10.1101/2021.09.04.458962] [Reference Citation Analysis]
8 Lei Y, Han P, Tian D. Protein arginine methyltransferases and hepatocellular carcinoma: A review. Transl Oncol 2021;14:101194. [PMID: 34365222 DOI: 10.1016/j.tranon.2021.101194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]